Cannabis bioengineering generally involves the use of genetic modifications to scale up the production process of cannabis and its extracts. Cannabinoids such as THC, CBD, and several others present in the cannabis plant matrix only exist in small quantities. This makes it unfit for use on an industrial scale especially in terms of the pharmaceutical use of the product. Cannabinoids are majorly concentrated in trichomes which are short outgrowth on the cannabis bud. This makes the stem, stalk, leaves unusable in terms of getting the necessary cannabinoids. This apparent need led to the introduction of genetic modifications to cannabis cultivation.
Republican Senators James Lankford (Oklahoma) and Pete Ricketts (Nebraska) have introduced a bill that seeks…
New blue hues and flavors from top breeders have arrived. The post New Blueberry weed…
While there are many studies showing potential and promise for using various compounds in cannabis…
Trump's declaration of drug cartels as terrorist organizations and his war cry to ramp up…
A recent poll conducted by the University of Houston’s Hobby School of Public Affairs has…
Candies, Z, OGs, and more from Leafly’s senior editor. The post David Downs’ sickest weed…